This week in USA TODAY: ""As we've tracked GLP-1 use over the last couple of years, we've just seen these dramatic increases of use," said Tricia Rodriguez, who led the study for Truveta Research, and both drugs are "really revolutionizing the treatment of both diabetes and obesity."" Learn more about our GLP-1 comparative effectiveness study, which was recently published in JAMA Internal Medicine: #GLP1 #Semaglutide #Tirzepatide #WeightLoss #WeightLossDrugs #PeerReviewed #JAMA #ResearchPublication #HealthData #HealthTech #HealthcareData #HealthcareTech #PrescriptionTrends #PrescriptionData #MedicalData #MedicalTechnology #MedTech #JAMAInternalMedicine #RealWorldData #RealWorldEvidence #AI #HealthAI #HealthcareAI #MedicalAI #Innovation #HealthInnovation #HealthcareInnovation #MedicalInnovation Thanks for being an incredible partner in this work, Ellie
If you're giving it to a developing child, what is the effect of that going to be 10 years from now
Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial
Laser & Light Treatments Cosmetic Laser Dermatology offers the latest technology, including 60+ laser and light devices, to treat concerns such as wrinkles and sagging skin
La vitamine B12, aussi appele cobalamine, joue un rle cl dans plusieurs fonctions essentielles : la formation des globules rouges
Ethical and Legal Implications for Doctors and Patients The situation with BPC-157 raises difficult ethical questions in medicine